Your browser doesn't support javascript.
loading
Ad hoc afatinib in an eldery lung cancer patient with EGFR exon 19 deletion L747-A750>P.
Guida, Annalisa; Tassi, Valentina; Facchinetti, Francesco; Marchetti, Giovanni; Caprera, Cecilia; Ragusa, Mark; Tiseo, Marcello; Bracarda, Sergio; Bracarda, Sergio.
Afiliação
  • Guida A; Medical Oncology, Azienda Ospedaliera Santa Maria, Terni, Italy.
  • Tassi V; Thoracic Surgery Unit, Azienda Ospedaliera Santa Maria, Terni, Italy. vtassi82@gmail.com.
  • Facchinetti F; Université Paris-Saclay, Institut Gustave Roussy, Inserm, Biomarqueurs prédictifs et nouvelles stratégies thérapeutiques en oncologie, Villejuif, France.
  • Marchetti G; Division of Pathology, Azienda Ospedaliera Santa Maria, Terni, Italy.
  • Caprera C; Division of Pathology, Azienda Ospedaliera Santa Maria, Terni, Italy.
  • Ragusa M; Thoracic Surgery Unit, Azienda Ospedaliera Santa Maria, Terni, Italy.
  • Tiseo M; Department of Medicine and Surgery, University Hospital of Parma, Parma, Italy.
  • Bracarda S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Bracarda S; Medical Oncology, Azienda Ospedaliera Santa Maria, Terni, Italy.
Adv Respir Med ; 90(3): 234-235, 2022.
Article em En | MEDLINE | ID: mdl-35731116

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article